Advertisement

Molecular Biology of Atherothrombotic Brain Infarction and Its Role in Vascular Dementia

  • F. M. Yatsu
  • R. Kasturi
  • R. Alam
  • J. Kraus
  • S. Rogers
  • T. J. DeGraba
  • S. Hanson
Conference paper

Abstract

Dementia due to vascular disease results from ischemic infarctions affecting crucial areas of brain by virtue of their critical nature for memory, such as the hippocampus/dentate gyrus or dorsal medial nucleus of the thalamus; the aggregate mass of infarcts; and the bilateral involvement of cortical damage. However, the most important factor causing ischemic infarction is atherosclerotic vascular disease in both large and small arteries and arterioles. Since the best therapy for both strokes and vascular dementia is prevention, it follows that insights into the fundamental molecular biological mechanisms of atherosclerosis in patients with vascular dementia should provide clues for identifying genetic predisposition and planning rational therapeutic intervention. The hope and expectation is that the offending atherosclerotic changes can be prevented and reversed, thereby averting any ischemic brain injury and the potential for secondary dementia.

Keywords

Vascular Dementia Lipid Research Clinic Helsinki Heart Study Fractional Catabolic Rate Atheroma Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alam R, Yatsu FM, Tsui L, Alam S (1989) Receptor-medicated uptake and “retroendocytosis” of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim Biophys Acta 1004:292–299PubMedGoogle Scholar
  2. 2.
    Aruffo A, Seed B (1989) Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc Natl Acad Sci USA 80:8573–8577Google Scholar
  3. 3.
    Bass F, Bikker H, van Ommen GB, de Vijldes JJM (1984) Unusual scarcity of restriction site polymorphism in the human thyroglobulin gene. A linkage study suggesting autosomal dominance of a defective thyroglobulin allele. Human Genet 67:301–305CrossRefGoogle Scholar
  4. 4.
    Bihara-Varga M, Szekely J, Gruber E (1981) Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease: the influence of various risk factors. Atherosclerosis 40:337–345CrossRefGoogle Scholar
  5. 5.
    Blin N, Stafford DN (1976) A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid Res 3:2303–2308PubMedGoogle Scholar
  6. 6.
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–37PubMedCrossRefGoogle Scholar
  7. 7.
    Frick MH, Elo O, Hapaa K et al. (1987) Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med 317:1237–1245PubMedCrossRefGoogle Scholar
  8. 8.
    Ghosh DK, Meon KMJ (1989) Identification of gonadotropin inducible, high density lipoprotein receptors in the solubilized membrane from rat ovary. Biochem Biophys Res Commun 134:1006–1014CrossRefGoogle Scholar
  9. 9.
    Gown AM, Tsukada T, Ross R (1986) Human atherosclerosis. II. Immunocytochemical analysis of cellular composition of human atherosclerotic lesions. Am J Pathol 125:191–207PubMedGoogle Scholar
  10. 10.
    Grotta JC, Yatsu FM, Pettigrew LC et al. (1989) Prediction of carotid progression by lipid and hematologic measurements. Neurology 39:1325–1331PubMedGoogle Scholar
  11. 11.
    Gubler U, Hoffman BJ (1983) A simple and very efficient method for generating cDNA libraries. Gene 25:263–269PubMedCrossRefGoogle Scholar
  12. 12.
    Jonasson L, Holm J, Skalli O et al. (1986) Regional accumulation of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis 6:131–138Google Scholar
  13. 13.
    Mathews CME (1957) The theory of trace experiments with 131-I-labelled plasma proteins. Phys Med Biol 2:36CrossRefGoogle Scholar
  14. 14.
    McFarlane AJ (1958) Efficient trace labeling of proteins with iodine. Nature 183:53CrossRefGoogle Scholar
  15. 15.
    Murai A, Tanaka T, Miyahara T, Kameyama M (1981) Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 12:167–172PubMedCrossRefGoogle Scholar
  16. 16.
    Nestel PJ, Billington T (1981) Effect of probucol on low density lipoprotein removal and high density lipoprotein synthesis. Atherosclerosis 38:203–209PubMedCrossRefGoogle Scholar
  17. 17.
    Oppenheimer MJ, Oram JF, Bierman EL (1986) Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation. J Biol Chem 263:19318–19323Google Scholar
  18. 18.
    Ross R (1986) The pathogenesis of atherosclerosis: an update. N Engl J Med 314:488–500PubMedCrossRefGoogle Scholar
  19. 19.
    Saku K, Gastside PS, Hynd BA, Kashyap ML (1985) Mechanism of action of gemfibrozil on lipoprotein metabolism. J Clin Invest 75:1702–1712PubMedCrossRefGoogle Scholar
  20. 20.
    Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503–517PubMedCrossRefGoogle Scholar
  21. 21.
    The Lipid Research Clinics (1984) Coronary primary prevention trial results. JAMA 251:351–364CrossRefGoogle Scholar
  22. 22.
    Yatsu FM, Alam R, Alam S (1983) Enhancement of cholesteryl ester metabolism in culture human monocyte-derived macrophages by verapamil. Biochim Biophys Acta 847:77–81CrossRefGoogle Scholar
  23. 23.
    Yatsu FM, Becker C, McLeroy KR et al. (1986) Community hospital-based stroke programs: North Carolina, Oregon and New York. I. Goals, objectives and data collection procedures. Stroke 17:276–284PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • F. M. Yatsu
    • 1
  • R. Kasturi
    • 1
  • R. Alam
    • 1
  • J. Kraus
    • 1
  • S. Rogers
    • 1
  • T. J. DeGraba
    • 1
  • S. Hanson
    • 1
  1. 1.Department of Neurology, Medical School at HoustonUniversity of TexasHoustonUSA

Personalised recommendations